Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Summary

The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.

Conditions

• Multiple Sclerosis
• NMO Spectrum Disorder
• Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
• Radiologically Isolated Syndrome
• Clinically Isolated Syndrome

Sponsors & Collaborators

• Charite University, Berlin, Germany

  collaborator OTHER

• Ruhr University of Bochum

  collaborator OTHER

• Technische Universität Dresden

  collaborator OTHER

• University Hospital, Lille

  collaborator OTHER

• Casa di Cura IGEA

  collaborator OTHER

• General University Hospital, Prague

  collaborator OTHER

• Hoffmann-La Roche

  collaborator INDUSTRY

• Bristol-Myers Squibb

  collaborator INDUSTRY

• Imcyse SA

  collaborator INDUSTRY

• AB Science

  collaborator INDUSTRY

• Nocturne UG

  collaborator UNKNOWN

• Aalto University

  collaborator OTHER

• icometrix

  lead INDUSTRY

Principal Investigators

• Friedemann Paul, PhD, MD · Max Delbrück Center - Charite University, Berlin, Germany

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2024-03-01

Primary Completion

2027-04-30

Completion

2027-04-30

Countries

• Czechia
• Germany

Study Locations